10.84
Inogen Inc stock is traded at $10.84, with a volume of 287.95K.
It is down -8.52% in the last 24 hours and up +13.99% over the past month.
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
See More
Previous Close:
$11.85
Open:
$11.86
24h Volume:
287.95K
Relative Volume:
1.30
Market Cap:
$259.11M
Revenue:
$331.52M
Net Income/Loss:
$-52.69M
P/E Ratio:
-4.8178
EPS:
-2.25
Net Cash Flow:
$-14.47M
1W Performance:
-9.29%
1M Performance:
+13.99%
6M Performance:
+33.01%
1Y Performance:
+45.70%
Inogen Inc Stock (INGN) Company Profile
Name
Inogen Inc
Sector
Industry
Phone
805-562-0500
Address
859 WARD DRIVE, GOLETA, CA
Compare INGN with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
INGN
Inogen Inc
|
10.84 | 259.11M | 331.52M | -52.69M | -14.47M | -2.25 |
![]()
ABT
Abbott Laboratories
|
128.22 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
105.02 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
![]()
SYK
Stryker Corp
|
396.07 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
![]()
EW
Edwards Lifesciences Corp
|
70.99 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Inogen Inc Stock (INGN) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-15-24 | Upgrade | William Blair | Mkt Perform → Outperform |
Aug-08-23 | Downgrade | JP Morgan | Overweight → Neutral |
Jul-14-23 | Downgrade | Needham | Buy → Hold |
Jan-17-23 | Downgrade | William Blair | Outperform → Mkt Perform |
Dec-09-21 | Upgrade | Needham | Hold → Buy |
Nov-02-21 | Upgrade | JP Morgan | Underweight → Neutral |
Aug-05-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
Jun-04-21 | Upgrade | William Blair | Mkt Perform → Outperform |
Dec-14-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Jul-23-20 | Downgrade | Needham | Buy → Hold |
May-06-20 | Reiterated | Needham | Buy |
Nov-06-19 | Upgrade | Needham | Hold → Buy |
Sep-13-19 | Reiterated | Piper Jaffray | Overweight |
Aug-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
Aug-08-19 | Downgrade | Stifel | Buy → Hold |
Aug-07-19 | Downgrade | Needham | Buy → Hold |
Jun-28-19 | Downgrade | Needham | Strong Buy → Buy |
May-08-19 | Downgrade | JP Morgan | Overweight → Neutral |
May-08-19 | Reiterated | Needham | Strong Buy |
Feb-27-19 | Reiterated | Needham | Strong Buy |
Nov-20-18 | Upgrade | Needham | Buy → Strong Buy |
Nov-07-18 | Reiterated | Needham | Buy |
Sep-10-18 | Downgrade | Needham | Strong Buy → Buy |
Aug-22-18 | Resumed | Stifel | Buy |
Aug-08-18 | Reiterated | Needham | Strong Buy |
Jun-06-18 | Initiated | KeyBanc Capital Mkts | Sector Weight |
May-01-18 | Reiterated | Needham | Strong Buy |
Feb-28-18 | Reiterated | Needham | Strong Buy |
View All
Inogen Inc Stock (INGN) Latest News
Global Airway Clearance Devices for Cystic Fibrosis Market to Show Positive Growth at a CAGR of ~5% by 2032 | DelveInsight - The Malaysian Reserve
Here's Why You Should Add Inogen Stock to Your Portfolio Now - Zacks Investment Research
Inogen appoints Sahney to board - HME News
Inogen Alliance ranked #32 in Environment Analyst’s - 3BL Media
Inogen's (INGN) "Hold" Rating Reaffirmed at Needham & Company LLC - MarketBeat
Inogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom West - sharewise
Inogen Appoints Mira Kirti Sahney to Board of Directors - citybiz
Inogen Board Reshuffle with Sahney Appointment - TipRanks
Former Medtronic Pelvic Health President Joins Inogen Board: Strategic Move in Respiratory Care Leadership - StockTitan
Inogen, Inc. (NASDAQ:INGN) Short Interest Down 6.2% in January - MarketBeat
Inogen’s (INGN) Hold Rating Reiterated at Needham & Company LLC - Defense World
Investors in Inogen (NASDAQ:INGN) have unfortunately lost 75% over the last five years - Yahoo Finance UK
Inogen Stock Gains Following Solid Preliminary Q4 Revenues - MSN
Head-To-Head Analysis: Anteris Technologies Global (NASDAQ:AVR) vs. Inogen (NASDAQ:INGN) - Defense World
Terra Nexus, UAE Joins Inogen Alliance - Yahoo Finance
Inogen Stock May Gain on Deal With Yuwell to Expand Global Reach - Yahoo Finance
Tosyalı Launches one of the World’s Largest Self-Consumption Solar Power Plant Projects - GlobeNewswire Inc.
Inogen Announces Strategic Collaboration with Yuwell - MSN
Inogen, Inc. announced that it expects to receive $27.209763 million in funding -January 24, 2025 - Marketscreener.com
Inogen partners with Yuwell to expand product portfolio, accelerate entry into Chinese market - Seeking Alpha
Arab Health 2025|Yuwell Medical Announces Strategic Investment and Partnership with Inogen in Respiratory Health - Barchart
Inogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic Collaboration With Yuwell - Business Wire
Assenagon Asset Management S.A. Has $683,000 Stock Holdings in Inogen, Inc. (NASDAQ:INGN) - MarketBeat
Assenagon Asset Management S.A. Sells 160,429 Shares of Inogen, Inc. (NASDAQ:INGN) - Defense World
Inogen (INGN) Moves to Strong Buy: Rationale Behind the Upgrade - Yahoo Finance
Inogen, Inc. (NASDAQ:INGN) Held Back By Insufficient Growth Even After Shares Climb 32% - Simply Wall St
Inogen, Inc. (NASDAQ:INGN) Short Interest Down 6.2% in December - MarketBeat
Barclays PLC Purchases 23,398 Shares of Inogen, Inc. (NASDAQ:INGN) - Defense World
Inogen Insiders Benefitted From Selling Stock At US$8.56 - Simply Wall St
Inogen expects prelim Q4 revenue in the range of $79M to $80M - MSN
Inogen stock holds as revenue forecast beats consensus - Investing.com India
Inogen reports growth in Q4 and full year 2024 revenue By Investing.com - Investing.com Australia
Inogen stock holds as revenue forecast beats consensus By Investing.com - Investing.com Australia
Inogen (NASDAQ:INGN) Given "Hold" Rating at Needham & Company LLC - MarketBeat
Inogen, Inc. Provides Revenue Guidance for the Fourth Quarter of 2024 and Full Year 2024 - Marketscreener.com
Inogen, Inc. (NASDAQ:INGN) Stock Position Increased by JPMorgan Chase & Co. - Defense World
Inogen (NASDAQ:INGN) Stock Crosses Above Fifty Day Moving AverageHere's Why - MarketBeat
Inogen (NASDAQ:INGN) Stock Crosses Above Fifty Day Moving Average – Here’s Why - Defense World
Inogen reports growth in Q4 and full year 2024 revenue - Investing.com India
Inogen Announces Preliminary Fourth Quarter and Full Year 2024 Revenue - Business Wire
Inogen receives FDA 510(k) clearance for SIMEOX 200 airway clearance device - News-Medical.Net
Jane Street Group LLC Cuts Stake in Inogen, Inc. (NASDAQ:INGN) - Defense World
Jane Street Group LLC Sells 250,473 Shares of Inogen, Inc. (NASDAQ:INGN) - MarketBeat
Inogen Inc Stock (INGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):